Iceland· IS-EU/1/12/805/003-004
AMYViD
A florbetapir (18f) product containing florbetapirum inn, registered in Iceland by Eli Lilly Nederland B.V.*. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Florbetapir (18f) is registered in 11 of 19 countries.
Countries holding a registration under ATC V09AX05 (florbetapir (18f)), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Florbetapir (18f) · ATC V09AX05
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Florbetapirum INN
- Manufacturer
- Eli Lilly Nederland B.V.*
- Country
- Iceland (IS)
- ATC code
- V09AX05
- ATC class
- Florbetapir (18F)
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09AX05
Florbetapir (18f), as other registers publish it.
- DenmarkAmyvidEli Lilly Netherland B.V.
- FinlandAmyvidEli Lilly Nederland B.V.
- DenmarkAmyvidEli Lilly Netherland B.V.
- FinlandAmyvidEli Lilly Nederland B.V.
- PolandAmyvidEli Lilly Nederland B.V.
- PolandAmyvidEli Lilly Nederland B.V.
- IcelandAMYViDEli Lilly Nederland B.V.*
- CzechiaAMYVIDEli Lilly Nederland B.V., Utrecht
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e86a01c8-30c2-4316-8520-9d4dba343bae GET /v1/drugs/e86a01c8-30c2-4316-8520-9d4dba343bae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "V09AX05",
"marketed": false,
"strength": "1900 MBq/ml",
"ma_number": "EU/1/12/805/003-004",
"substance": "Florbetapirum INN",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "41288"
}See everything about florbetapir (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.